Exscientia

Founded in 2012 in Oxford, UK, Exscientia is a pioneer in AI-driven precision drug design. The company develops small-molecule drugs designed by its AI platform, advancing candidates in oncology, immunology, and inflammation. Exscientia partners with pharma and maintains internal programs, with several AI-designed molecules reaching clinical trials. It became one of the first AI drug-discovery com...